Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
NCT00504387 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2012-12-21
Summary
Oral burning can have a multitude of reasons. Recent neurophysiologic study results suggest that a primary burning mouth disorder (BMD) may be a peripheral and/or a central neuropathic disorder. The aim of this study is to first identify patients with a primary burning mouth disorder by excluding other possible causes for oral burning. By means of qualitative and quantitative sensory testing and a gustatory examination in the individual patient the investigators want to find out whether neurosensory differences exist between patients with a primary BMD and controls and whether gustatory and neurosensory deficits always coexist in BMD-patients.
Conditions
- Burning Mouth Syndrome
- Taste Disorder
- Orofacial Pain
Sponsors & Collaborators
-
Deutsche Gesellschaft für Zahn-, Mund- und Kieferheilkunde e.V.
collaborator UNKNOWN -
Markus R. Fussnegger
lead OTHER
Principal Investigators
-
Ingrid Peroz, PD Dr. · Charité - Universitätsmedizin Berlin, Center for dental and craniofacial sciences, Department of restorative dentistry, Assmannshauser Str. 4-6, D-14197 Berlin
-
Markus R Fussnegger, Dr. · Charité - Universitätsmedizin Berlin, Center for dental and craniofacial sciences, Department of restorative dentistry, Assmannshauser Str. 4-6, D-14197 Berlin
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-04-30
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Burning Mouth Syndrome: Symptoms and Management
NCT07016555 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome
NCT05309681 ·Status: COMPLETED
-
Evaluation and Treatment of Oral Soft Tissue Diseases
NCT00001601 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome
NCT06217731 ·Status: COMPLETED ·Phase: NA
-
Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
NCT05729529 ·Status: UNKNOWN ·Phase: NA
-
Reducing Patient Memory Recall in the Burning Mouth Patient Population
NCT05819697 ·Status: RECRUITING
-
Effects of Photobiomodulation in Burning Mouth Syndrome
NCT04034849 ·Status: COMPLETED ·Phase: NA
-
Alpha Lipoic Acid for Burning Mouth
NCT00387543 ·Status: COMPLETED
-
Effect to the Photobiomodulation in the Burning Mouth Syndrome
NCT05871580 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
NCT02580734 ·Status: COMPLETED ·Phase: NA
-
Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome
NCT04313907 ·Status: UNKNOWN ·Phase: PHASE4
-
Therapeutic Options for Treatment of Burning Mouth Syndrome
NCT04475614 ·Status: COMPLETED ·Phase: NA
-
Burning Mouth Syndrome: Effects of Occlusal Splint Therapy
NCT07344909 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Evaluating the Laser Diode Effect Burning Mouth Syndrome
NCT02757612 ·Status: COMPLETED ·Phase: NA
-
Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
NCT06195137 ·Status: COMPLETED ·Phase: NA
-
Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
NCT05872789 ·Status: COMPLETED ·Phase: NA
-
The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study
NCT01754740 ·Status: COMPLETED ·Phase: NA
-
Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01)
NCT01425983 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
NCT02690844 ·Status: WITHDRAWN ·Phase: PHASE4
-
Oral and Olfactory Complications of Recovered COVID-19 Patients
NCT04791436 ·Status: RECRUITING
-
Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
NCT04535973 ·Status: COMPLETED
-
Effectiveness of an Intervention Bundle on Thirst Intensity and Dry Mouth Among Patients in ICUs
NCT03215251 ·Status: COMPLETED ·Phase: NA
-
HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
NCT01931293 ·Status: UNKNOWN ·Phase: NA
-
Olfactory and Taste Disturbances in Sjogren's Syndrome
NCT04909112 ·Status: UNKNOWN ·Phase: NA
-
Symptoms of Frey's Syndrome
NCT05738395 ·Status: RECRUITING